Paper565450
L-DOPA reversal of hyperdopaminergic behaviour.
Ezrin-Waters C and 1 other. Life Sci, 1978. Cited by 49 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. L-DOPA reversal of hyperdopaminergic behaviour. Papers, record 565450. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/565450
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Behavior | Major topic |
| Dopamine | Major topic |
| Levodopa | Major topic |
| Stereotyped Behavior | Major topic |
| Animals | |
| Apomorphine | |
| Carbidopa | |
| Humans | |
| Male | |
| Rats | |
| Reserpine |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30,197,787 | "Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemic. | J Syst Integr Neurosci | 2017 | https://conductscience.org/library/papers/30197787 | PubMed |
| 8,331,352 | The effects of acute levodopa withdrawal on motor performance and dopaminergic receptor sensitivity in patients with Parkinson's disease. | J Neurol Neurosurg Psychiatry | 1993 | https://conductscience.org/library/papers/8331352 | PubMed |
| 7,370,539 | Treatment of infertility with levodopa. | Br Med J | 1980 | https://conductscience.org/library/papers/7370539 | PubMed |
| 6,815,701 | The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy. | Psychopharmacology (Berl) | 1982 | https://conductscience.org/library/papers/6815701 | PubMed |
| 6,136,552 | Sustained levodopa therapy in tardive dyskinesia. | J Neurol Neurosurg Psychiatry | 1983 | https://conductscience.org/library/papers/6136552 | PubMed |
| 6,128,757 | Levodopa and receptor sensitivity modification in tardive dyskinesia. | Psychopharmacology (Berl) | 1982 | https://conductscience.org/library/papers/6128757 | PubMed |
| 6,126,905 | Left hemisphere hyperactivity in schizophrenia: abnormality inherent to psychosis or neuroleptic side-effects? | Psychopharmacology (Berl) | 1982 | https://conductscience.org/library/papers/6126905 | PubMed |
| 6,106,902 | Reduction of dopaminergic supersensitivity by a single dose of amphetamine. | Naunyn Schmiedebergs Arch Pharmacol | 1980 | https://conductscience.org/library/papers/6106902 | PubMed |
| 3,936,899 | Sub-chronic administration of (-)-3-PPP and central dopamine receptor sensitivity changes. | J Neural Transm | 1985 | https://conductscience.org/library/papers/3936899 | PubMed |
| 2,934,514 | L-dopa reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatum. | J Neural Transm | 1985 | https://conductscience.org/library/papers/2934514 | PubMed |
| 111,273 | Dopaminergic supersensitivity: influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/111273 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/565450
GET https://conductscience.org/api/papers/v1/565450/authors